Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 2 June

Jessica Amir
June 2, 2021

Morning Bell 1 June

Paulina Peters
June 1, 2021

Morning Bell 31 May

Paulina Peters
May 31, 2021

Weekly Wrap 28 May

Jessica Amir
May 28, 2021

Morning Bell 28 May

Sophia Mavridis
May 28, 2021

Morning Bell 27 May

Paulina Peters
May 27, 2021

Morning Bell 26 May

Jessica Amir
May 26, 2021

Morning Bell 25 May

Jessica Amir
May 25, 2021

Morning Bell 24 May

Jessica Amir
May 24, 2021

Weekly Wrap 21 May

Jessica Amir
May 21, 2021

Morning Bell 21 May

Sophia Mavridis
May 21, 2021